Tpl-2 acts in concert with Ras and Raf-1 to activate mitogen-activated protein kinase - PubMed (original) (raw)
Tpl-2 acts in concert with Ras and Raf-1 to activate mitogen-activated protein kinase
C Patriotis et al. Proc Natl Acad Sci U S A. 1994.
Abstract
Mitogenic signals initiated at the plasma membrane by extracellular factors acting on receptor tyrosine kinases or G protein-coupled receptors are transmitted to the nucleus through an intricate signaling network. Components of this network participate, upon stimulation, in a complex array of phosphorylation-dependent protein-protein interactions which leads to the formation of transient multimolecular complexes. Complexes containing products of the protooncogenes ras and raf-1 and the protein kinase MEK-1 activate the mitogen-activated protein kinases (MAPKs), which play a central role in the integration of different mitogenic signals by directly phosphorylating cytoplasmic and nuclear targets. In this report we present evidence that the kinase encoded by the tumor progression locus 2 gene (Tpl-2) contributes to the activation of the MAPK cascade. MAPK activation induced by the Tpl-2 protein is blocked by dominant negative mutants of Ras and Raf-1, whereas a kinase-deficient Tpl-2 mutant down-regulates mitogenic signals induced by v-Ha-Ras or v-Raf. These data suggest that Tpl-2 activates the MAPK cascade, perhaps through its participation in the assembly of Ras/Raf-1-containing multimolecular complexes.
Similar articles
- Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase.
Salmeron A, Ahmad TB, Carlile GW, Pappin D, Narsimhan RP, Ley SC. Salmeron A, et al. EMBO J. 1996 Feb 15;15(4):817-26. EMBO J. 1996. PMID: 8631303 Free PMC article. - Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
Chesnel F, Bonnec G, Tardivel A, Boujard D. Chesnel F, et al. Dev Biol. 1997 Aug 1;188(1):122-33. doi: 10.1006/dbio.1997.8631. Dev Biol. 1997. PMID: 9245517 - Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway.
Geppert TD, Whitehurst CE, Thompson P, Beutler B. Geppert TD, et al. Mol Med. 1994 Nov;1(1):93-103. Mol Med. 1994. PMID: 8790605 Free PMC article. - The insulin/Ras pathway of adipocytic differentiation of 3T3 L1 cells: dissociation between Raf-1 kinase and the MAPK/RSK cascade.
Porras A, Santos E. Porras A, et al. Int J Obes Relat Metab Disord. 1996 Mar;20 Suppl 3:S43-51. Int J Obes Relat Metab Disord. 1996. PMID: 8680477 Review. - Signal transduction pathways involving the Raf proto-oncogene.
Williams NG, Roberts TM. Williams NG, et al. Cancer Metastasis Rev. 1994 Mar;13(1):105-16. doi: 10.1007/BF00690421. Cancer Metastasis Rev. 1994. PMID: 8143342 Review.
Cited by
- A central role of IKK2 and TPL2 in JNK activation and viral B-cell transformation.
Voigt S, Sterz KR, Giehler F, Mohr AW, Wilson JB, Moosmann A, Kieser A. Voigt S, et al. Nat Commun. 2020 Feb 4;11(1):685. doi: 10.1038/s41467-020-14502-x. Nat Commun. 2020. PMID: 32019925 Free PMC article. - A melanocyte lineage program confers resistance to MAP kinase pathway inhibition.
Johannessen CM, Johnson LA, Piccioni F, Townes A, Frederick DT, Donahue MK, Narayan R, Flaherty KT, Wargo JA, Root DE, Garraway LA. Johannessen CM, et al. Nature. 2013 Dec 5;504(7478):138-42. doi: 10.1038/nature12688. Epub 2013 Nov 3. Nature. 2013. PMID: 24185007 Free PMC article. - Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression.
Bennett AM, Hausdorff SF, O'Reilly AM, Freeman RM, Neel BG. Bennett AM, et al. Mol Cell Biol. 1996 Mar;16(3):1189-202. doi: 10.1128/MCB.16.3.1189. Mol Cell Biol. 1996. PMID: 8622663 Free PMC article. - Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40.
Eliopoulos AG, Wang CC, Dumitru CD, Tsichlis PN. Eliopoulos AG, et al. EMBO J. 2003 Aug 1;22(15):3855-64. doi: 10.1093/emboj/cdg386. EMBO J. 2003. PMID: 12881420 Free PMC article. - NF-kappaB1 p105 negatively regulates TPL-2 MEK kinase activity.
Beinke S, Deka J, Lang V, Belich MP, Walker PA, Howell S, Smerdon SJ, Gamblin SJ, Ley SC. Beinke S, et al. Mol Cell Biol. 2003 Jul;23(14):4739-52. doi: 10.1128/MCB.23.14.4739-4752.2003. Mol Cell Biol. 2003. PMID: 12832462 Free PMC article.
References
- Biochim Biophys Acta. 1991 Dec 10;1072(2-3):215-29 - PubMed
- Nature. 1994 Jun 2;369(6479):411-4 - PubMed
- Cell Regul. 1991 Dec;2(12):965-78 - PubMed
- Mol Cell Biol. 1992 May;12(5):2222-9 - PubMed
- EMBO J. 1992 Jun;11(6):2159-66 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous